Room 3 | 4:45 pm - 5:15 pm | Monday, March 27, 2023
Ferring Pharmaceuticals, who built its business on reproductive and maternal health, has been moving into gastroenterology with a revolutionary treatment for Clostridium difficile, better known as C. diff. In order to understand this patient population and develop direct-to-patient/caregiver materials, Ferring hired MarketVision Research to create and run an online community of patients.
C. diff is commonly found in older adults and those that take antibiotics often for chronic conditions. One of our biggest challenges was getting patients to share what can be unpleasant and embarrassing digestive symptoms. We needed to help them feel comfortable and safe when telling very personal stories. We will share how we overcame this and other challenges to help Ferring and their agencies truly understand the patient’s needs.
Key takeaways:
Speakers:
More sessions
Since COVID-19, the research fraternity has seen drastic changes in its approach toward consumer research and user research. Technology adoption is at its peak and online research platforms have become [...]
James Wycherley, author of “Transforming Insight,” CEO of the IMA and host of the Insight Forums and Transforming Insight podcast, summarizes 18 years of best practice discussions with IMA members [...]
The speed at which the marketplace is changing means that there is little room for error in quickly developing actionable insights from research. This makes it even more important for [...]